Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood test could catch deadly lung side effect early

NCT ID NCT07340892

Recruiting now Diagnosis Sponsor: Zhou Chengzhi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test that uses NMR technology to spot lung inflammation caused by immunotherapy drugs. The goal is to catch this serious side effect early, so doctors can treat it quickly. The study will include 60 people with lung cancer who are on immunotherapy, some with and some without lung inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

drug or radiation exposure-related interstitial lung disease lung cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHECKPOINT INHIBITOR-RELATED PNEUMONITIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Guangzhou Medical University

    RECRUITING

    Guangzhou, Guangdong, 510100, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.